astroviru
common
caus
viral
gastroenter
throughout
world
caus
outbreak
diarrheal
diseas
school
hospit
nurs
home
militari
base
sever
recent
report
highlight
impact
rna
viru
immunocompromis
host
addit
role
gastroenter
patient
one
astroviru
subgroup
report
caus
enceph
allogen
hematopoiet
stem
cell
transplant
hsct
recipi
children
xlink
agammaglobulinemia
molecular
techniqu
includ
reversetranscript
polymeras
chain
reaction
rtpcr
rna
sequenc
nextgener
sequenc
demonstr
presenc
subgroup
cerebrospin
fluid
csf
brain
tissu
infect
patient
immunohistochem
stain
biopsi
tissu
confirm
presenc
invas
infect
known
antivir
treatment
avail
central
nervou
system
cn
infect
fatal
case
report
date
addit
studi
need
determin
preval
astroviru
infect
transplant
patient
bocaviru
human
parvoviru
caus
upper
lower
respiratori
tract
infect
gastroenter
enceph
children
infect
common
late
fall
winter
commonli
present
rhinorrhea
fever
cough
wheez
diarrhea
thirti
percent
children
develop
hypoxia
varieti
radiograph
find
report
includ
peribronchi
cuf
lobar
infiltr
pleural
effus
nosocomi
infect
occur
bocaviru
infect
report
first
week
follow
hematopoiet
stem
cell
transplant
present
fever
rhinorrhea
cough
diarrhea
hypoxia
viru
detect
high
quantiti
plasma
nasopharyng
aspir
stool
fecal
shed
occur
sever
week
month
clinic
resolut
infect
sever
prolong
diarrhea
describ
liver
transplant
hematopoiet
stem
cell
recipi
suggest
bocaviru
like
respiratori
syncyti
viru
rsv
parainfluenza
may
play
role
develop
bronchiol
obliteran
manifest
chronic
reject
lung
transplant
date
data
antivir
efficaci
bocaviru
chikungunya
viru
mosquitoborn
alphaviru
transmit
aed
aegypti
aed
albopictu
tropic
infect
caus
epidem
diseas
india
thailand
malaysia
madagascar
reunion
island
endem
eastern
central
southern
africa
chikungunya
report
st
martin
epidem
spread
throughout
caribbean
central
america
south
america
florida
infect
spread
local
via
aegypti
incub
period
day
infect
present
high
fever
headach
myalgia
arthralgia
resembl
dengu
arthralgia
typic
symmetr
involv
larg
joint
particularli
leg
arm
frank
arthriti
may
also
occur
interphalang
joint
wrist
ankl
half
patient
also
develop
rash
maculopapular
petechi
bullou
commonli
locat
trunk
occasion
involv
face
extrem
palm
sole
ocular
pain
also
report
rare
meningoenceph
myocard
hepat
occur
symptom
resolv
day
although
arthralgia
joint
stiff
may
persist
week
month
fever
resolv
sever
manifest
infect
fatal
outcom
report
patient
underli
diabet
lung
diseas
chronic
neurolog
condit
laboratori
find
includ
lymphopenia
thrombocytopenia
elev
transaminas
hypocalcemia
diagnosi
may
made
serolog
rtpcr
igm
antibodi
develop
fever
resolv
typic
week
symptom
onset
current
known
effect
antivir
therapi
chikungunya
widespread
outbreak
infect
reunion
island
indian
ocean
organ
tissu
donor
screen
presenc
chikungunya
infect
corneal
donor
found
serolog
pcr
evid
infect
serum
corneal
tissu
transmiss
infect
corneal
transplant
presum
occur
report
transmiss
chikungunya
solid
organ
stem
cell
transplant
date
although
report
infect
asia
europ
north
america
travel
endem
area
risk
transmiss
clinic
cours
infect
patient
requir
studi
februari
aworldwid
outbreak
sever
respiratori
infect
occur
infect
patient
sever
month
countri
sever
affect
southern
china
hong
kong
canada
welldescrib
healthcareassoci
outbreak
eighti
percent
affect
previous
healthi
comorbid
condit
outbreak
began
guangdong
provinc
china
novemb
global
travel
spread
rapidli
multipl
contin
infect
numer
health
care
worker
rapidli
fatal
cours
infect
even
healthi
host
remark
name
sever
acut
respiratori
syndrom
sar
infect
quickli
determin
due
new
strain
coronaviru
group
virus
known
caus
human
diseas
sinc
patient
initi
note
high
fever
myalgia
headach
cough
subsequ
becam
dyspneic
product
cough
seen
nearli
one
third
patient
rash
lymphadenopathi
absent
lymphopenia
thrombocytopenia
mild
elev
transaminas
prolong
prothrombin
time
elev
ddimer
elev
lactat
dehydrogenas
ldh
creatin
kinas
ck
hyponatremia
common
lab
find
chest
radiograph
reveal
focal
airspac
consolid
ground
glass
opac
initi
without
interstiti
infiltr
characterist
viral
pneumon
lower
lung
field
predomin
pleural
effus
mediastin
lymphadenopathi
gener
absent
histopatholog
find
lung
biopsi
autopsi
includ
diffus
alveolar
damag
consist
adult
respiratori
distress
syndrom
ard
signific
alveolar
edema
minim
inflamm
viral
inclus
treatment
includ
corticosteroid
intraven
oral
ribavirin
although
publish
data
yet
avail
human
anim
model
suggest
monoclon
antibodi
sar
coronaviru
sarscov
effect
decreas
viral
replic
improv
outcom
overal
case
fatal
rate
sar
epidem
nearli
novel
coronaviru
rapidli
isol
identifi
caus
sar
sequenc
allow
rtpcr
serolog
test
develop
sar
outbreak
toronto
liver
transplant
recipi
fatal
infect
visit
medic
center
outpati
clinic
visit
nearli
year
posttranspl
dissemin
infect
describ
lung
transplant
recipi
viru
detect
lung
bowel
lymph
node
liver
kidney
skelet
muscl
brain
autopsi
tissu
viral
load
significantli
higher
transplant
recipi
immunocompet
counterpart
last
nearli
report
case
sarscov
report
may
addit
case
report
unclear
reason
septemb
initi
report
infect
anoth
novel
human
coronaviru
began
saudi
arabia
rapid
spread
neighbor
egypt
iran
jordan
kuwait
lebanon
qatar
oman
yemen
unit
arab
emir
contin
airlin
travel
middl
east
respiratori
syndrom
coronaviru
mer
cov
report
caus
sever
respiratori
tract
infect
adult
patient
mortal
rate
high
commonli
diabet
mellitu
end
stage
renal
diseas
median
incub
period
day
rang
day
patient
often
present
fever
cough
dyspnea
diarrhea
close
contact
infect
case
andor
travel
area
infect
activ
coryza
headach
nausea
vomit
abdomin
pain
also
report
laboratori
find
includ
thrombocytopenia
leukopenia
lymphopenia
elev
transaminas
ldh
coinfect
respiratori
virus
report
sarscov
health
care
worker
risk
infect
dromedari
camel
report
harbor
infect
arabian
peninsula
although
mode
transmiss
infect
yet
elucid
sever
case
mer
cov
infect
report
hematopoiet
stem
cell
solid
organ
transplant
recipi
develop
bilater
pulmonari
infiltr
respiratori
failur
acut
renal
failur
leukopenia
thrombocytopenia
elev
transaminas
time
without
fever
difficult
grow
cell
cultur
mer
cov
may
diagnos
rtpcr
respiratori
secret
viru
detect
techniqu
urin
stool
well
increas
yield
test
recommend
multipl
specimen
differ
site
eg
nasopharyng
swab
sputum
bal
fluid
serum
stool
test
use
rtpcr
avail
cdc
local
health
depart
usa
due
risk
transmiss
infect
health
care
worker
contact
airborn
precaut
recommend
care
suspect
merscov
infect
patient
random
control
clinic
trial
antivir
merscov
ribavirin
mycophenol
mofetil
immunosuppress
agent
use
commonli
transplant
vitro
activ
viru
ribavirin
combin
interferon
demonstr
promis
decreas
lung
injuri
viral
replic
rhesu
macaqu
infect
merscov
retrospect
cohort
studi
describ
use
ribavirin
interferon
twenti
patient
sever
infect
demonstr
earli
surviv
benefit
wherea
coronavirus
made
world
headlin
sar
epidem
merscov
emerg
coronavirus
group
group
known
decad
caus
upper
respiratori
tract
infect
fall
winter
month
coronaviru
group
report
caus
upper
lower
respiratori
tract
infect
immunocompet
host
netherland
coronaviru
group
report
caus
pneumonia
hong
kong
franc
nonsar
coronavirus
recent
associ
sever
lower
respiratori
tract
infect
hospit
patient
includ
lung
liver
transplant
recipi
coronaviru
isol
hematopoiet
stem
cell
transplant
recipi
fever
cough
associ
interstiti
alveolar
pulmonari
infiltr
pancytopenia
may
present
radiograph
infiltr
commonli
interstiti
although
alveolar
pleural
effus
may
present
pneumothorax
note
minor
patient
diagnosi
may
made
cultur
human
hepatoma
cell
line
rtpcr
hepat
e
endem
develop
countri
report
caus
epidem
diseas
asia
africa
latin
america
via
transmiss
travelrel
infect
report
return
endem
area
poor
sanit
recent
report
highlight
import
role
infect
transplant
recipi
hepat
e
viru
hev
rna
viru
four
major
genotyp
presum
reservoir
pig
wild
boar
deer
mollusk
seropreval
survey
indic
infect
blood
donor
even
franc
usa
signific
area
hepat
e
preval
hepat
epidem
infect
describ
ingest
contamin
water
mollusk
undercook
deer
boar
pig
meat
blood
transfusiontransmit
infect
also
describ
incub
period
two
nine
week
patient
develop
jaundic
abdomin
pain
anorexia
nausea
fever
chill
may
occur
well
although
rash
unusu
diagnosi
made
rtpcr
detect
hev
rna
present
week
infect
symptom
occur
igm
antibodi
develop
symptom
resolv
approxim
week
infect
elev
transaminas
occur
peak
approxim
week
infect
viremia
resolv
within
week
infect
viru
remain
detect
stool
sever
week
viremia
resolv
igg
appear
serum
igg
antibodi
persist
year
acut
infect
approxim
patient
acut
hev
infect
develop
fulmin
hepat
acut
hepat
failur
presenc
pregnanc
underli
chronic
liver
diseas
eg
chronic
hepat
c
infect
cirrhosi
increas
risk
sever
infect
histopatholog
find
liver
biopsi
includ
lymphocyt
infiltr
portal
triad
chronic
hepat
appear
rare
immunocompet
host
diseas
organ
transplant
recipi
character
high
incid
chronic
infect
acut
infect
patient
progress
fibrosi
eventu
cirrhosi
reactiv
infect
describ
liver
allogen
hsct
recipi
nearli
half
infect
becam
chronic
liver
transplant
recipi
appear
increas
risk
chronic
infect
result
reactiv
hev
transplant
well
acut
graft
hepat
reactiv
primari
infect
extrahepat
manifest
infect
transplant
recipi
includ
glomerulonephr
neurolog
involv
fdaapprov
therapi
hev
infect
although
decreas
immunosuppress
appear
help
control
viremia
chronic
infect
transplant
recipi
small
studi
interferon
alpha
ribavirin
report
decreas
viremia
patient
popul
lymphocyt
choriomening
viru
lcmv
gain
notorieti
pathogen
solid
organ
transplant
first
two
outbreak
donortransmit
infect
describ
addit
donortransmit
outbreak
recent
occur
usa
australia
four
cluster
donorderiv
infect
occur
usa
date
lcmv
rodentborn
old
world
arenaviru
caus
asymptomat
mild
selflimit
ill
immunocompet
host
rodent
especi
common
hous
mice
laboratori
mice
hamster
often
acquir
infect
congenit
result
lifelong
asymptomat
excret
viru
urin
saliva
fece
human
infect
occur
via
direct
contact
infect
rodent
aerosol
infect
excreta
eg
clean
soil
cage
bed
symptom
describ
immunocompet
human
includ
fever
headach
myalgia
csf
find
consist
asept
mening
eg
lymphocyt
pleocytosi
normal
host
infect
selflimit
carri
mortal
rate
less
transplant
cluster
infect
lcmv
fatal
case
patient
present
within
first
month
posttranspl
fever
diarrhea
abdomin
pain
dyspnea
rash
headach
lethargi
hypotens
presenc
pulmonari
infiltr
variabl
thrombocytopenia
anemia
present
variabl
peripher
leukocyt
lymphocyt
count
acut
hepat
elev
transaminas
note
well
coagulopathi
prolong
protim
patient
develop
rapidli
progress
multisystem
failur
encephalopathi
prior
death
one
cluster
donor
evid
infect
multipl
tissu
test
pet
hamster
present
donor
home
sever
week
prior
donat
found
lcmv
multipl
tissu
viru
isol
hamster
ident
isol
infect
transplant
recipi
survivor
cluster
kidney
recipi
treat
discontinu
immun
suppress
except
corticosteroid
intraven
ribavirin
similar
approach
use
recent
case
four
donorderiv
infect
outbreak
usa
alon
lcmv
infect
like
common
previous
recogn
transplant
recipi
detail
workup
potenti
organ
donor
asept
mening
meningoenceph
may
prevent
transmiss
case
whether
lcmv
infect
occur
posttranspl
recipi
exposur
pet
hamster
hous
mice
unknown
human
metapneumoviru
singlestrand
rna
paramyxoviru
worldwid
endem
caus
respiratori
tract
infect
children
elderli
immunocompromis
adult
outbreak
report
longterm
care
facil
infect
occur
late
winter
earli
spring
januari
april
similar
season
respiratori
syncyti
viru
rsv
upper
lower
respiratori
tract
symptom
includ
rhinorrhea
sore
throat
cough
dyspnea
fever
describ
infect
describ
follow
lung
transplant
result
acut
pneumonia
diffus
alveolar
damag
hyalin
membran
format
lung
transplant
recipi
metapneumoviru
pneumonia
mortal
rate
higher
risk
acut
chronic
reject
renal
transplant
recipi
pneumon
due
metapneumoviru
report
year
posttranspl
one
studi
hsct
recipi
human
metapneumoviru
isol
via
rtpcr
symptomat
patient
undergo
bronchoscopi
carri
mortal
rate
infect
occur
within
first
week
follow
transplant
character
fever
nasal
congest
cough
rapid
develop
hypoxia
hypotens
progress
pneumonia
diffus
alveolar
hemorrhag
three
five
patient
pleural
effus
nodular
infiltr
may
seen
may
help
differenti
infect
rsv
coinfect
rsv
rhinoviru
cmv
describ
follow
lung
transplant
ribavirin
demonstr
decreas
human
metapneumoviru
replic
lung
mous
model
intraven
ribavirin
effect
treatment
sever
lung
transplant
recipi
metapneumoviru
infect
measl
outbreak
occur
multipl
state
recent
year
attack
rate
greater
among
suscept
patient
includ
unvaccin
children
adult
affect
patient
develop
fever
cough
coryza
associ
characterist
rash
infect
may
complic
pneumonia
enceph
dissemin
signific
mortal
note
solid
organ
hsct
recipi
infect
associ
wane
immun
diagnos
serolog
data
antivir
treatment
measl
mump
increasingli
report
usa
case
report
larg
multist
outbreak
patient
present
acut
onset
unilater
bilater
parot
infect
may
complic
orchiti
oophor
pancreat
mastiti
mening
enceph
infect
may
diagnos
serolog
via
pcr
antivir
investig
treatment
mump
enhanc
effort
immun
measl
mump
pretranspl
well
activ
surveil
posttranspl
warrant
result
reemerg
vaccineprevent
virus
recent
guidelin
suggest
vaccin
measl
mump
rubella
mmr
vaccin
year
follow
hematopoiet
stem
cell
transplant
patient
without
evid
graftversushost
diseas
possibl
patient
undergo
solid
organ
transplant
evid
protect
measl
mump
eg
posit
igg
antibodi
vaccin
prior
initi
immunosuppress
therapi
norovirus
calicivirus
caus
million
case
gastroenter
annual
usa
half
epidem
gastroenter
worldwid
infect
acquir
via
consumpt
contamin
food
includ
raw
oyster
fruit
veget
via
ingest
swim
contamin
water
spread
via
fomit
person
person
infect
extrem
contagi
often
spread
rapidli
result
prolong
fecal
shed
affect
patient
resolut
symptom
outbreak
infect
describ
multipl
set
includ
militari
barrack
restaur
hospit
longterm
care
facil
school
cruis
ship
infect
may
asymptomat
present
sudden
onset
nausea
vomit
diarrhea
incub
period
less
h
studi
suggest
vomit
common
children
diarrheal
symptom
predomin
infant
adult
infect
common
winter
month
symptom
last
day
attack
rate
outbreak
health
care
worker
substanti
risk
infect
norovirus
cultur
vitro
rtpcr
enzym
immunoassay
eia
assay
avail
diagnosi
stool
specimen
noroviru
infect
solid
organ
transplant
recipi
common
mark
risk
chronic
relaps
infect
infect
present
wateri
diarrhea
caus
volum
deplet
acut
renal
failur
renal
transplant
recipi
patient
may
symptomat
month
may
shed
viru
stool
year
hematopoiet
stem
cell
transplant
recipi
report
develop
acut
chronic
diarrheal
diseas
noroviru
infect
associ
subsequ
develop
chronic
gvhd
receipt
cord
blood
induct
fludarabin
receipt
alemtuzumab
report
risk
factor
noroviru
infect
set
nosocomi
outbreak
infect
hsct
unit
result
infect
staff
patient
sepsi
bacteri
transloc
complic
sever
case
treatment
noroviru
infect
transplant
recipi
investig
random
control
trial
date
reduct
immunosuppress
result
clearanc
infect
one
intestin
transplant
recipi
noroviru
infect
avail
antivir
therapi
date
norovirus
highli
resist
disinfect
propag
prolong
transmiss
mani
environ
parvoviru
infect
common
adult
serolog
evid
prior
infect
children
parvoviru
infect
caus
erythema
infectiosum
febril
ill
characterist
slap
cheek
rash
adult
acut
parvoviru
infect
develop
flulik
ill
sometim
result
arthropathi
pathogen
erythroid
progenitor
cell
parvoviru
caus
sever
anemia
patient
underli
hemolyt
disord
hydrop
fetali
pregnanc
recent
year
neurolog
involv
includ
meningoenceph
describ
may
common
immunocompromis
host
transplant
recipi
anemia
common
present
infect
fever
occur
patient
arthralgia
rash
occur
less
affect
pancytopenia
may
present
manifest
describ
transplant
popul
includ
hepat
myocard
pneumon
enceph
mening
peripher
neuriti
collaps
glomerulopathi
cn
infect
may
develop
sequela
includ
seizur
cognit
deficit
stroke
muscl
wast
donortransmit
infect
describ
present
allograft
dysfunct
fever
arthralgia
pancytopenia
often
without
rash
chronic
recurr
anemia
may
seen
posttranspl
well
pure
red
cell
aplasia
parvoviru
infect
also
associ
subsequ
develop
thrombot
microangiopathi
kidney
transplant
recipi
includ
cluster
case
iran
hemophagocyt
lymphohistiocytosi
also
describ
popul
signific
frequent
find
parvoviru
dna
renal
allograft
pre
posttranspl
investig
transplant
popul
parvoviru
may
associ
chronic
cellular
allograft
reject
diagnosi
parvoviru
infect
may
made
serolog
pcr
bone
marrow
examin
immunocompet
host
yield
serolog
test
especi
igm
limit
transplant
recipi
may
mount
adequ
antibodi
respons
infect
rtpcr
blood
bone
marrow
involv
tissu
necessari
detect
infect
mani
case
infect
may
respond
intraven
immunoglobulin
ivig
relaps
occur
immunosuppress
host
publish
data
use
antivir
parvoviru
infect
human
polyoma
virus
bk
viru
jc
viru
well
known
pathogen
transplant
discuss
elsewher
recent
year
three
addit
polyoma
virus
describ
potenti
pathogen
immunocompromis
host
like
bk
jc
virus
frequent
caus
asymptomat
primari
infect
healthi
patient
capabl
establish
latent
infect
reactiv
set
immun
suppress
ki
wu
virus
name
institut
discov
karolinska
institutet
washington
univers
isol
children
acut
respiratori
symptom
includ
wheez
well
set
pneumonia
respiratori
infect
also
describ
hivinfect
patient
higher
viral
load
demonstr
lower
count
ki
wu
polyomavirus
isol
nasopharyng
sputum
bronchoalveolar
lavag
specimen
hematopoiet
stem
cell
solid
organ
transplant
recipi
virus
also
detect
transbronchi
biopsi
specimen
lung
transplant
recipi
mani
case
asymptomat
coinfect
viral
bacteri
pathogen
report
rtpcr
result
interpret
caution
transplant
recipi
sever
infect
describ
date
avail
data
role
decreas
immunosuppress
therapi
use
antivir
agent
develop
treatment
infect
ki
wu
polyomavirus
merkel
cell
carcinoma
neuroendocrin
malign
skin
common
immunocompromis
host
includ
transplant
recipi
tumor
contain
polyoma
viru
name
merkel
cell
polyomaviru
mcpyv
viru
also
found
respiratori
secret
asymptomat
transplant
recipi
studi
polyomavirus
ongo
transplant
popul
rotaviru
common
caus
enter
worldwid
common
pathogen
healthi
children
age
becom
increasingli
recogn
pathogen
pediatr
adult
recipi
solid
organ
transplant
epidem
occur
transmiss
primarili
winter
spring
affect
patient
present
wateri
diarrhea
nausea
vomit
abdomin
pain
case
gastrointestin
bleed
colon
ulcer
infect
may
diagnos
antigen
detect
stool
specimen
use
elisa
latex
agglutin
quantit
pcr
infect
gener
selflimit
wean
immunosuppress
acut
phase
ill
publish
data
antivir
activ
rotaviru
treatment
remain
symptomat
rotaviru
associ
high
risk
acut
cellmedi
reject
intestin
transplant
recipi
propos
relat
poor
absorpt
immunosuppress
agent
set
vomit
diarrhea
well
immun
reactiv
gastrointestin
tractassoci
lymphocyt
set
infect
hsct
recipi
rotaviru
infect
may
difficult
differenti
clinic
histopatholog
gvhd
live
oral
tetraval
reassort
rotaviru
vaccin
rotashield
wyethayerst
laboratori
st
david
pa
licens
recommend
routin
immun
infant
usa
voluntarili
withdrawn
market
due
associ
intestin
intussuscept
note
postmarket
surveil
two
addit
rotaviru
vaccin
studi
rotateq
merck
compani
whitehous
station
nj
rotarix
glaxosmithklin
biolog
rixensart
belgium
vaccin
oral
contain
live
viru
thu
contraind
highli
immunocompromis
patient
fecal
viru
shed
note
vaccin
transmiss
vaccineassoci
viru
household
member
note
rotarix
current
vaccin
guidelin
immunocompromis
host
recommend
hsct
solid
organ
transplant
recipi
receiv
live
viru
vaccin
household
contact
patient
immun
defici
may
vaccin
transplant
recipi
chang
diaper
week
vaccin
usual
durat
viral
shed
stool
west
nile
viru
wnv
initi
isol
febril
patient
west
nile
provinc
uganda
enzoot
africa
asia
middl
east
part
mediterranean
europ
caus
asymptomat
diseas
selflimit
febril
flulik
ill
flaviviru
first
detect
northeastern
usa
caus
outbreak
infect
late
summer
earli
fall
throughout
usa
sinc
bird
primari
reservoir
infect
mosquito
acquir
lifelong
infect
bite
virem
bird
spread
infect
salivari
gland
speci
includ
human
subsequ
bite
human
infect
incub
period
day
approxim
infect
asymptomat
patient
develop
west
nile
fever
character
fever
malais
anorexia
nausea
myalgia
headach
occasion
lymphadenopathi
one
symptomat
patient
develop
mening
andor
enceph
mening
present
photophobia
phonophobia
meningismu
hyperreflexia
csf
analysi
reveal
lymphocyt
pleocytosi
glucos
usual
normal
patient
enceph
develop
alter
mental
statu
cranial
nerv
palsi
seizur
movement
disord
minor
patient
develop
rapid
asymmetr
weak
may
progress
flaccid
paralysi
mimick
poliomyel
associ
hyporeflexia
areflexia
acut
neuromuscular
respiratori
failur
may
develop
carri
mortal
rate
hemorrhag
fever
characterist
flavivirus
also
describ
presenc
sever
weak
hyporeflexia
patient
meningoenceph
rais
suspicion
wnv
infect
mri
may
demonstr
mening
periventricular
enhanc
sometim
mimick
ischem
chang
transmiss
wnvvia
dialysi
suggest
transmiss
via
blood
transfus
organ
transplant
well
document
immunocompromis
host
central
nervou
system
involv
common
although
csf
pleocytosi
may
minim
communityacquir
infect
report
follow
solid
organ
transplant
occur
month
year
posttranspl
studi
wnv
infect
outbreak
toronto
note
liver
kidney
heart
transplant
recipi
time
risk
symptomat
infect
normal
host
case
recipi
particip
outdoor
activ
without
use
insect
repel
person
protect
measur
fever
often
preced
neurolog
symptom
delay
serolog
respons
note
transplant
cohort
infect
carri
mortal
rate
versu
gener
popul
colorado
outbreak
transplant
recipi
kidney
liver
kidneypancrea
lung
hsct
develop
infect
requir
hospit
ten
develop
meningoenceph
one
develop
acut
flaccid
paralysi
without
enceph
three
patient
meningoenceph
paralysi
two
patient
die
mortal
three
suffer
signific
neurolog
sequela
appear
transplant
recipi
like
develop
meningoenceph
set
acut
west
nile
viru
infect
immunocompet
host
perhap
higher
mortal
rate
prolong
infect
also
occur
sever
case
wnvinfect
report
hsct
recipi
infect
occur
month
posttranspl
welldescrib
case
engraft
calcineurin
inhibitorbas
prophylaxi
treatment
chronic
graftversushost
diseas
fever
lethargi
progress
bilater
extrem
weak
hyporeflexia
areflexia
present
csf
contain
white
blood
igg
igm
neg
csf
blood
case
diagnosi
wnv
infect
made
pcr
perform
serum
csf
describ
patient
die
diagnosisof
wnv
infect
immunocompet
host
may
made
serolog
via
rtpcr
igm
antibodi
captur
assay
avail
becom
posit
csf
day
onset
symptom
nonimmunosuppress
host
serum
antibodi
develop
csf
igg
appear
approxim
day
later
antibodi
presenc
may
confirm
viral
neutral
studi
igm
antibodi
may
persist
serum
month
infect
resolut
igg
may
persist
year
hematopoiet
stem
cell
recipi
note
immunocompromis
patient
demonstr
delay
seroconvers
make
diagnosi
acut
infect
difficult
time
nucleic
acid
test
plasma
andor
csf
use
diagnost
test
set
antivir
agent
proven
efficaci
thetreat
wnv
infect
ribavirin
possess
vitro
activ
demonstr
poor
clinic
efficaci
ivig
high
titer
antiwnv
antibodi
eg
israel
infect
endem
demonstr
signific
clinic
benefit
anim
model
although
antibodi
titer
low
immun
globulin
deriv
us
donor
proven
ineffect
treat
acut
infect
report
success
treatment
donortransmit
wnv
infect
liver
transplant
recipi
reduc
immunosuppress
administ
plasma
seroposit
blood
donor
publish
overal
case
fatal
rate
infect
wnv
significantli
higher
rate
transplant
recipi
unlik
case
neuroinvas
viral
infect
sever
initi
clinic
present
predict
theprognosi
wnv
infect
survivor
frequent
suffer
prolong
fatigu
myalgia
cognit
deficit
memori
loss
tremor
parkinson
excess
somnol
postur
instabl
report
phase
trial
vaccin
promis
transplant
recipi
educ
transmiss
west
nile
viru
urg
remov
stagnant
water
collect
use
insect
repel
outdoor
dusk
later
summer
fall
order
prevent
infect
virus
remain
signific
elus
pathogen
infect
patient
follow
solid
organ
hematopoiet
stem
cell
transplant
day
viru
clearli
behind
us
immunosuppress
chang
posttranspl
longev
increas
molecular
diagnost
method
dramat
improv
serolog
may
limit
valu
immunocompromis
host
diagnosi
acut
infect
well
detect
reactiv
latent
infect
multiplex
quantit
realtim
pcr
assay
avail
detect
multipl
virus
includ
panel
pcr
detect
respiratori
virus
cn
pathogen
sensit
techniqu
evalu
care
transplant
popul
specif
potenti
util
marker
earli
infect
surveil
monitor
impact
communityacquir
respiratori
viral
infect
develop
acut
reject
bronchiol
obliteran
lung
transplant
appear
signific
warrant
studi
continu
vigil
detect
emerg
viral
infect
continu
studi
potenti
antivir
therapi
transplant
popul
like
improv
patient
surviv
